Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Randomized Phase II Study of Carboplatin and Pemetrexed With Or Without Selpercatinib (LY3527723) In Patients With Non Squamous RET Positive Stage IV Non Small Cell Lung Cancer and Progression of Disease On Prior RET Directed Therapy (Lung MAP Sub Study)
NCT Number:
NCT05364645
Phase:
II
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Lung
Study Objectives:
Study Documents
(MUSC NetID required for document access)